Nanoparticle-Antibody Conjugates for Cystatin C Immunoassay
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current turbidimetric immunoassays for measuring Cystatin C suffer from low accuracy, precision, and are prone to interference from lipids and hemoglobin, leading to long assay times and imprecision.
Innovation Solution
A turbidimetric method using nanoparticle-antibody conjugates with carefully adjusted particle size and antibody composition, allowing for a stronger and faster turbidimetric signal, reduced interference, and improved linearity, while maintaining accuracy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional turbidimetric immunoassays are used for measuring Cystatin C, then the assay can be performed with standard reagents, but the accuracy and precision are low and interference from lipids and hemoglobin occurs
Solution Approach 1:
The patent changes the physical parameter of particle size by using nanoparticles with diameter of 5-50 nm instead of conventional larger particles. This parameter change reduces the interference from lipids and hemoglobin while improving the accuracy and precision of Cystatin C measurements through enhanced light scattering properties at this specific size range
Solution Approach 2:
The patent creates composite nanoparticle-antibody conjugates by combining nanoparticle cores with antibody molecules. This composite structure integrates the light scattering advantages of nanoparticles with the specific binding capability of antibodies, achieving both reduced interference and maintained measurement accuracy
2Productivity
If conventional turbidimetric immunoassays are used, then the assay procedure is simple, but the assay time is long and precision is poor
Solution Approach 1:
The patent optimizes the nanoparticle size parameter to 5-50 nm diameter, which enhances the light scattering signal intensity. This parameter optimization enables faster assay completion while simultaneously improving precision through stronger turbidimetric signals that reduce measurement variability
Solution Approach 2:
The patent replaces conventional detection methods with turbidimetric detection based on light scattering from nanoparticles. This substitution enables automated, high-speed measurement with improved precision through optical detection rather than manual or slower automated methods
3Illumination intensity
If larger particle sizes are used in turbidimetric assays, then the signal strength increases, but the interference from lipids and hemoglobin also increases
Solution Approach 1:
The patent identifies and optimizes the critical parameter of particle size to the 5-50 nm range. This specific parameter change achieves the optimal balance where sufficient light scattering signal is generated while the smaller size reduces non-specific interactions with lipids and hemoglobin, thereby minimizing interference
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method provides enhanced accuracy, precision, and reduced interference from triglycerides, enabling faster and more reliable Cystatin C measurements.
Implementation Method 1
assessing the human Cystatin C content by measuring the change in turbidity of said mixture
Implementation Method 2
particle enhanced turbidimetric immunoassay for assessing human Cystatin C
Data Source
AI summary
There is a demand for improved turbidimetric immunoassays for human Cystatin C in biological samples, especially in human clinical samples of body fluids. The present invention provides a turbidimetric immunoassay method and reagent set enabling measurement of human Cystatin C by turbidimetric methods, resulting in a surprisingly stronger and faster turbidimetric signal than in the present state of the art. The increased and faster signal is accomplished by the use of new reagents and compositions, and enables shorter assay times and kinetic reading with a stronger signal, improving overall assay speed and quality. Improved robustness to lipid interference and improved linearity is achieved.